Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
Chronic hepatitis B virus (HBV) infection leads to cirrhosis and hepatocellular carcinoma (HCC). Antiviral agents are thought to reduce HCC development, but agents such as lamivudine (LAM) have a high rate of drug resistance. We compared the incidence of HCC in 472 entecavir (ETV)-treated patients a...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2012
|
| 在线阅读: | https://doi.org/10.1002/hep.26180 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26180 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|